Yuriy Stukov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yuriy Stukov has a total of 130 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey Phillip Jacobs
University of Florida
23 shared publications - Giles John Peek
University of Florida
10 shared publications Dan Neal
University of Florida
9 shared publications- Mark Steven Bleiweis
University of Florida
9 shared publications Giles J. Peek
University of Florida
8 shared publicationsOmar M. Sharaf
University of Florida
8 shared publications
Latest Publications
- 29 June 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Nitric oxide in Extracorporeal Membrane Oxygenation Sweep Gas Promotes Oxygenator Longevity: A Technical Case Report
In the accompanying article in this issue, we reported the survival of a 4 month old infant with severe necrotizing pneumonia due to respiratory syncytial virus (RSV) and methicillin-resistant Staphylococcus aureus (MRSA), resulting in cardiogenic shock and respiratory failure, who required a total of 233 days of extracorporeal membrane oxygenator (ECMO) support. In this article, we report the function of the ECMO membrane (oxygenator). To preserve oxygenator function, nitric oxide was added to the ECMO sweep gas (sNO). Despite prolonged ECMO support, a single membrane lung functioned effectively for 5 months. Structural analysis of the polymethylpentene (PMP) oxygenator postdecannulation revealed no thrombus or fibrin deposition. This is the first known structural evaluation of a PMP oxygenator after prolonged clinical use with sNO, suggesting that sNO may prolong oxygenator longevity and maintain functional performance.
- 29 June 2026
- Published by Wolters Kluwer Health in ASAIO Journal
Nitric oxide in Extracorporeal Membrane Oxygenation Sweep Gas Promotes Oxygenator Longevity: A Technical Case Report
In the accompanying article in this issue, we reported the survival of a 4 month old infant with severe necrotizing pneumonia due to respiratory syncytial virus (RSV) and methicillin-resistant Staphylococcus aureus (MRSA), resulting in cardiogenic shock and respiratory failure, who required a total of 233 days of extracorporeal membrane oxygenator (ECMO) support. In this article, we report the function of the ECMO membrane (oxygenator). To preserve oxygenator function, nitric oxide was added to the ECMO sweep gas (sNO). Despite prolonged ECMO support, a single membrane lung functioned effectively for 5 months. Structural analysis of the polymethylpentene (PMP) oxygenator postdecannulation revealed no thrombus or fibrin deposition. This is the first known structural evaluation of a PMP oxygenator after prolonged clinical use with sNO, suggesting that sNO may prolong oxygenator longevity and maintain functional performance.
- 7 January 2026
- Published by European Association of Cardiothoracic Surgery (EACTS Publishing Ltd) in Multimedia Manual of Cardio-Thoracic Surgery
- Vol. 2026
Traumatic diaphragmatic rupture and left chest wall herniation
Blunt diaphragmatic rupture is a rare injury with a high mortality rate. The pathophysiological mechanism of diaphragmatic rupture is hypothesized as an increase in intra-abdominal pressure leading to muscular disruption and subsequent visceral herniation into the pleural cavity. Left-side ruptures are more common, as the right side is protected by the liver. Abdominal contents occupying the chest cavity can become ischaemic or could have been injured during the initial trauma and, additionally, might significantly compress the lung, leading to a variety of clinical presentations ranging from chest pain and peritonitis to increased rate of breathing or respiratory distress. In this video tutorial, we present a polytrauma patient after a motor vehicle collision, who sustained traumatic diaphragmatic rupture and left chest wall herniation.
- 7 January 2026
- Published by European Association of Cardiothoracic Surgery (EACTS Publishing Ltd) in Multimedia Manual of Cardio-Thoracic Surgery
- Vol. 2026
Traumatic diaphragmatic rupture and left chest wall herniation
Blunt diaphragmatic rupture is a rare injury with a high mortality rate. The pathophysiological mechanism of diaphragmatic rupture is hypothesized as an increase in intra-abdominal pressure leading to muscular disruption and subsequent visceral herniation into the pleural cavity. Left-side ruptures are more common, as the right side is protected by the liver. Abdominal contents occupying the chest cavity can become ischaemic or could have been injured during the initial trauma and, additionally, might significantly compress the lung, leading to a variety of clinical presentations ranging from chest pain and peritonitis to increased rate of breathing or respiratory distress. In this video tutorial, we present a polytrauma patient after a motor vehicle collision, who sustained traumatic diaphragmatic rupture and left chest wall herniation.
- 26 November 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (3) , 343-351
Impact of Congenital Heart Disease Versus Acquired Heart Disease: An Analysis of 181 Patients who Underwent Cardiac Transplantation
Purpose: We reviewed all 181 patients with pediatric and/or congenital heart disease (CHD) who underwent cardiac transplantation at the University of Florida from January 1, 2011, to March 1, 2022, and compared those with CHD with those who had acquired heart disease (AHD). Methods: Patient characteristics were assessed, stratified by CHD versus AHD. Continuous variables are presented as mean (SD); median[interquartile range](range). Categorical variables are presented as N (%). Univariable associations with long-term mortality were assessed with a Cox proportional-hazards model. The impact of CHD versus AHD on mortality was estimated with multivariable models. The Kaplan-Meier method was applied to estimate survival stratified by CHD versus AHD status. Results: Congenital heart disease was present in 112/181 patients = 61.9% of the total cohort. Acquired heart disease was present in 69/181 = 38.1%. More patients with CHD had prior cardiac surgery (95/112 = 84.8% vs 35/69 = 50.7%, P < .0001) and pretransplant liver dysfunction (19/112 = 17.0% vs 4/69 = 5.8%, P = .037). Congenital heart disease patients had longer bypass times (minutes): 148 (55.2); 137 [113-174] (72-526) versus 108 (40.3);101 [81-125] (59-300), P < .0001; longer cross clamp time (minutes): 85.9 (21.2); 85 [73-100] (49-152) versus 66.3 (14.7); 65 [55-75] (44-106), P < .0001; and lower minimum temperature on bypass (°C): 27.4 (4.3); 28 [24-31] (19-34) versus 31.6 (3.1); 32 [31-34] (20-36), P < .0001. Posttransplant length of stay (days) was longer in CHD patients: 34.5 (26.8); 27 [19-40] (3-158) versus 29.7 (48.2); 18 [15-26] (0-343), P = .0001. In multivariable analysis, CHD remained a risk factor for mortality after controlling for all variables significant in univariable modeling. Overall Kaplan-Meier 5-year survival in all 181 patients (95% confidence interval) = 85.8% (80.0%-92.1%). Kaplan-Meier 5-year survival = 77.4% (68.4%-87.5%) in CHD and 98.5% (95.6%-99.9%) in AHD, P < .0001. Conclusion: Congenital heart disease is a risk factor for mortality after cardiac transplantation. Efforts must be made to understand and mitigate this risk.
- 26 November 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (3) , 343-351
Impact of Congenital Heart Disease Versus Acquired Heart Disease: An Analysis of 181 Patients who Underwent Cardiac Transplantation
Purpose: We reviewed all 181 patients with pediatric and/or congenital heart disease (CHD) who underwent cardiac transplantation at the University of Florida from January 1, 2011, to March 1, 2022, and compared those with CHD with those who had acquired heart disease (AHD). Methods: Patient characteristics were assessed, stratified by CHD versus AHD. Continuous variables are presented as mean (SD); median[interquartile range](range). Categorical variables are presented as N (%). Univariable associations with long-term mortality were assessed with a Cox proportional-hazards model. The impact of CHD versus AHD on mortality was estimated with multivariable models. The Kaplan-Meier method was applied to estimate survival stratified by CHD versus AHD status. Results: Congenital heart disease was present in 112/181 patients = 61.9% of the total cohort. Acquired heart disease was present in 69/181 = 38.1%. More patients with CHD had prior cardiac surgery (95/112 = 84.8% vs 35/69 = 50.7%, P < .0001) and pretransplant liver dysfunction (19/112 = 17.0% vs 4/69 = 5.8%, P = .037). Congenital heart disease patients had longer bypass times (minutes): 148 (55.2); 137 [113-174] (72-526) versus 108 (40.3);101 [81-125] (59-300), P < .0001; longer cross clamp time (minutes): 85.9 (21.2); 85 [73-100] (49-152) versus 66.3 (14.7); 65 [55-75] (44-106), P < .0001; and lower minimum temperature on bypass (°C): 27.4 (4.3); 28 [24-31] (19-34) versus 31.6 (3.1); 32 [31-34] (20-36), P < .0001. Posttransplant length of stay (days) was longer in CHD patients: 34.5 (26.8); 27 [19-40] (3-158) versus 29.7 (48.2); 18 [15-26] (0-343), P = .0001. In multivariable analysis, CHD remained a risk factor for mortality after controlling for all variables significant in univariable modeling. Overall Kaplan-Meier 5-year survival in all 181 patients (95% confidence interval) = 85.8% (80.0%-92.1%). Kaplan-Meier 5-year survival = 77.4% (68.4%-87.5%) in CHD and 98.5% (95.6%-99.9%) in AHD, P < .0001. Conclusion: Congenital heart disease is a risk factor for mortality after cardiac transplantation. Efforts must be made to understand and mitigate this risk.
- 14 November 2025
- Published by Elsevier in The American Journal of Surgery
- p. 116718
Predicting successful general surgery matching in a Step 1 pass/fail era: Analysis of the Texas STAR database
- 14 November 2025
- Published by Elsevier in The American Journal of Surgery
- p. 116718
Predicting successful general surgery matching in a Step 1 pass/fail era: Analysis of the Texas STAR database
- Open Access
- 7 November 2025
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 21 (1) , 115-119
A Cath Lab Disaster: What Can We Do?
Aortic perforation is a rare and potentially fatal complication during percutaneous coronary intervention (PCI). This Interactive CME Case presents the case of a 47-year-old man who developed cardiac tamponade secondary to iatrogenic aortic perforation during PCI—a true nightmare.
- 7 November 2025
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 21 (1) , 115-119
Open AccessA Cath Lab Disaster: What Can We Do?
Aortic perforation is a rare and potentially fatal complication during percutaneous coronary intervention (PCI). This Interactive CME Case presents the case of a 47-year-old man who developed cardiac tamponade secondary to iatrogenic aortic perforation during PCI—a true nightmare.
- 4 November 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Extracorporeal Life Support in Lung Transplantation with Dual-Lumen Cannulas: A Systematic Review.
INPLASY2025110005 Extracorporeal Life Support in Lung Transplantation with Dual-Lumen Cannulas: A Systematic Review Keywords: ECLS, ECMO, Extracorporeal Membrane Oxygenation, Lung Transplantation, …
- 4 November 2025
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Extracorporeal Life Support in Lung Transplantation with Dual-Lumen Cannulas: A Systematic Review.
INPLASY2025110005 Extracorporeal Life Support in Lung Transplantation with Dual-Lumen Cannulas: A Systematic Review Keywords: ECLS, ECMO, Extracorporeal Membrane Oxygenation, Lung Transplantation, …
- Open Access
- 22 October 2025
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 21 (1) , 106-110
Rapidly Growing Coronary Aneurysm Following Purulent Pericarditis
Pericardiocentesis is associated with occasional infectious complications. Infected coronary artery aneurysms are rare and develop in patients undergoing coronary angiography. We describe a case of a 68-year-old man with prior myocardial infarction who presented with shortness of breath and chest pain 2 weeks after upper respiratory infection. After further workup revealed moderate pericardial effusion, the patient underwent pericardiocentesis and coronary angiography, which revealed multivessel coronary artery disease. The patient was transferred for elective surgical revascularization, which revealed a thickened pericardium with purulent pericardial fluid, suggestive of effusive constrictive pericarditis. Due to the risk for infectious complications, percutaneous coronary intervention was planned after antibiotic treatment. Repeat angiography revealed a coronary artery aneurysm in the proximal left anterior descending and diagonal 1 branch bifurcation, which was closed using an Mguard stent (Inspire MD) with an integrated polyethylene terephthalate net. Complete obliteration of the aneurysm was obtained using this approach.
- 22 October 2025
- Published by Houston Methodist DeBakey Heart & Vascular Center in Methodist DeBakey Cardiovascular Journal
- Vol. 21 (1) , 106-110
Open AccessRapidly Growing Coronary Aneurysm Following Purulent Pericarditis
Pericardiocentesis is associated with occasional infectious complications. Infected coronary artery aneurysms are rare and develop in patients undergoing coronary angiography. We describe a case of a 68-year-old man with prior myocardial infarction who presented with shortness of breath and chest pain 2 weeks after upper respiratory infection. After further workup revealed moderate pericardial effusion, the patient underwent pericardiocentesis and coronary angiography, which revealed multivessel coronary artery disease. The patient was transferred for elective surgical revascularization, which revealed a thickened pericardium with purulent pericardial fluid, suggestive of effusive constrictive pericarditis. Due to the risk for infectious complications, percutaneous coronary intervention was planned after antibiotic treatment. Repeat angiography revealed a coronary artery aneurysm in the proximal left anterior descending and diagonal 1 branch bifurcation, which was closed using an Mguard stent (Inspire MD) with an integrated polyethylene terephthalate net. Complete obliteration of the aneurysm was obtained using this approach.
- 18 September 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (7) , e70179
First Pediatric Lung Transplant Using the Paragonix BARO guard Preservation System
Background: Advances in donor organ preservation can potentially improve pediatric lung transplant outcomes. The ISHLT recommends that organ temperatures remain between 4°C and 6°C and that inflation pressures remain between 10 and 15 cm H 2 O during organ preservation. During traditional ice storage, temperature and inflation pressures rapidly fall below these suggested ranges. A recently developed preservation device, the Paragonix BAROguard Donor Lung Preservation System (BG) provides precise hypothermic and barometric control, ensuring that lung inflation pressure and tissue temperatures remain stable and within the ISHLT recommended range for the duration of storage. Here, we report the first clinical use of BG in a pediatric lung transplant case. Methods: A lung transplant was performed on a high‐risk pediatric recipient after lung preservation using the BG system. We evaluated the recipient for 187 days posttransplant during hospitalization. Results: Despite multiple significant risk factors, including neuroblastoma and hemolytic uremic syndrome complicated by thrombotic microangiopathy resulting in persistent coughing, shortness of breath, and poor oral intake, the lung transplant was successful, and the patient was discharged after 187 days. Conclusions: The BG system can be safely utilized in pediatric lung transplantation, and BG preservation can be safely implemented in high‐risk cases with poor clinical prognosis.
- 18 September 2025
- Published by Wiley in Pediatric Transplantation
- Vol. 29 (7) , e70179
First Pediatric Lung Transplant Using the Paragonix BARO guard Preservation System
Background: Advances in donor organ preservation can potentially improve pediatric lung transplant outcomes. The ISHLT recommends that organ temperatures remain between 4°C and 6°C and that inflation pressures remain between 10 and 15 cm H 2 O during organ preservation. During traditional ice storage, temperature and inflation pressures rapidly fall below these suggested ranges. A recently developed preservation device, the Paragonix BAROguard Donor Lung Preservation System (BG) provides precise hypothermic and barometric control, ensuring that lung inflation pressure and tissue temperatures remain stable and within the ISHLT recommended range for the duration of storage. Here, we report the first clinical use of BG in a pediatric lung transplant case. Methods: A lung transplant was performed on a high‐risk pediatric recipient after lung preservation using the BG system. We evaluated the recipient for 187 days posttransplant during hospitalization. Results: Despite multiple significant risk factors, including neuroblastoma and hemolytic uremic syndrome complicated by thrombotic microangiopathy resulting in persistent coughing, shortness of breath, and poor oral intake, the lung transplant was successful, and the patient was discharged after 187 days. Conclusions: The BG system can be safely utilized in pediatric lung transplantation, and BG preservation can be safely implemented in high‐risk cases with poor clinical prognosis.
- 23 July 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (1) , 68-75
Delayed Sternal Closure in Infants With Congenital Heart Disease: Can Chest Wall Edema Guide Timing?
Introduction: Delayed sternal closure is commonly used after complex congenital cardiac surgery in neonates and infants. The purpose of this study is to assess whether measurements on chest radiography can aid in determining optimal timing for delayed sternal closure. Methods: This is a retrospective study evaluating 103 neonates and infants Thoracic Radiographic Edema Ratio was calculated using chest radiography by dividing the thoracic cavity diameter by the total chest diameter, measured at the inferior aspect of T7. The ratios were measured on the day prior to surgery, the day of surgery, and each postoperative day until chest closure. Results: Peak swelling was noted to take place on postoperative days 1 and 2. Chest closure timing ranged from postoperative day 1 to postoperative day 5 with approximately 60% (62/103) of chest closures occurring on postoperative days 2 and 3. Mean Thoracic Radiographic Edema Ratio prior to surgery, immediately after surgery, and on the day of chest closure was 0.82, 0.77, and 0.8, respectively, indicating that patients had less swelling at time of closure than on postoperative day 0 ( P < .001). Conclusion: This study characterizes the natural history of postoperative chest wall edema. Timing of delayed sternal closure timing is a clinical decision based on multiple factors. The Thoracic Radiographic Edema Ratio can be a helpful tool in guiding delayed sternal closure timing in infants, as peak swelling is quantifiable, with evidence of peak chest wall edema appreciated on postoperative days 1 and 2.
- 23 July 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (1) , 68-75
Delayed Sternal Closure in Infants With Congenital Heart Disease: Can Chest Wall Edema Guide Timing?
Introduction: Delayed sternal closure is commonly used after complex congenital cardiac surgery in neonates and infants. The purpose of this study is to assess whether measurements on chest radiography can aid in determining optimal timing for delayed sternal closure. Methods: This is a retrospective study evaluating 103 neonates and infants Thoracic Radiographic Edema Ratio was calculated using chest radiography by dividing the thoracic cavity diameter by the total chest diameter, measured at the inferior aspect of T7. The ratios were measured on the day prior to surgery, the day of surgery, and each postoperative day until chest closure. Results: Peak swelling was noted to take place on postoperative days 1 and 2. Chest closure timing ranged from postoperative day 1 to postoperative day 5 with approximately 60% (62/103) of chest closures occurring on postoperative days 2 and 3. Mean Thoracic Radiographic Edema Ratio prior to surgery, immediately after surgery, and on the day of chest closure was 0.82, 0.77, and 0.8, respectively, indicating that patients had less swelling at time of closure than on postoperative day 0 ( P < .001). Conclusion: This study characterizes the natural history of postoperative chest wall edema. Timing of delayed sternal closure timing is a clinical decision based on multiple factors. The Thoracic Radiographic Edema Ratio can be a helpful tool in guiding delayed sternal closure timing in infants, as peak swelling is quantifiable, with evidence of peak chest wall edema appreciated on postoperative days 1 and 2.
- 9 June 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (1) , 106-112
A Single-Center Experience With En-Bloc Combined Heart+Liver Transplantation: Analysis of Eight Cases, Including Two Heart+Liver+Kidney Transplants
Objectives: Review our clinical experience with eight patients at the University of Florida undergoing En-bloc combined heart+liver transplantation (ECH + LTX). Methods: Continuous variables are reported as median (interquartile range = IQR) and categorical variables are reported as N (%). Results: Eight patients underwent ECH + LTX between August 2020 and May 2023 at the University of Florida, with triple heart+liver+kidney transplantation performed in 2/8 = 25%. Median age at ECH + LTX was 47.34 years (IQR = 33.66-53.37), and all eight patients were >18 years of age. Six out of eight patients (75%) had congenital heart disease (CHD): one had biventricular CHD and five had functionally univentricular circulation and Fontan failure. Two out of eight patients (25%) had structurally normal hearts and acquired heart disease: one patient with hemochromatosis and combined cardiac and hepatic failure with nonischemic restrictive cardiomyopathy and one patient with nonischemic cardiomyopathy and alcoholic cirrhosis. Median wait list time was 93 days (IQR = 27.50-176.25). Three patients (3/8 = 37.5%) were supported with an intra-aortic balloon pump prior to ECH + LTX, and two of these three patients were subsequently also supported with extracorporeal membrane oxygenation secondary to progressive decompensation prior to ECH + LTX. Median hospital length of stay was 147 days. Median posttransplant length of stay was of 29 days. Seven of eight patients survived ECH + LTX and are alive today. One patient died two days after ECH + LTX. Mean length of follow-up after ECH + LTX of seven surviving patients (years) is 3.60 ± 0.38 (median = 3.79, IQR = 3.05-4.38, range = 1.91-4.64). Conclusion: En-bloc heart-liver transplantation is an effective treatment option for patients with combined heart and liver failure.
- 9 June 2025
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
- Vol. 17 (1) , 106-112
A Single-Center Experience With En-Bloc Combined Heart+Liver Transplantation: Analysis of Eight Cases, Including Two Heart+Liver+Kidney Transplants
Objectives: Review our clinical experience with eight patients at the University of Florida undergoing En-bloc combined heart+liver transplantation (ECH + LTX). Methods: Continuous variables are reported as median (interquartile range = IQR) and categorical variables are reported as N (%). Results: Eight patients underwent ECH + LTX between August 2020 and May 2023 at the University of Florida, with triple heart+liver+kidney transplantation performed in 2/8 = 25%. Median age at ECH + LTX was 47.34 years (IQR = 33.66-53.37), and all eight patients were >18 years of age. Six out of eight patients (75%) had congenital heart disease (CHD): one had biventricular CHD and five had functionally univentricular circulation and Fontan failure. Two out of eight patients (25%) had structurally normal hearts and acquired heart disease: one patient with hemochromatosis and combined cardiac and hepatic failure with nonischemic restrictive cardiomyopathy and one patient with nonischemic cardiomyopathy and alcoholic cirrhosis. Median wait list time was 93 days (IQR = 27.50-176.25). Three patients (3/8 = 37.5%) were supported with an intra-aortic balloon pump prior to ECH + LTX, and two of these three patients were subsequently also supported with extracorporeal membrane oxygenation secondary to progressive decompensation prior to ECH + LTX. Median hospital length of stay was 147 days. Median posttransplant length of stay was of 29 days. Seven of eight patients survived ECH + LTX and are alive today. One patient died two days after ECH + LTX. Mean length of follow-up after ECH + LTX of seven surviving patients (years) is 3.60 ± 0.38 (median = 3.79, IQR = 3.05-4.38, range = 1.91-4.64). Conclusion: En-bloc heart-liver transplantation is an effective treatment option for patients with combined heart and liver failure.